Literature DB >> 3225413

Cigarette smoking and Dupuytren's contracture of the hand.

H S An1, S R Southworth, W T Jackson, B Russ.   

Abstract

Microvascular occlusion has been implicated as a possible causative factor of Dupuytren's contracture. Cigarette smoking is one of the most significant factors in the development of peripheral vasculopathy. The relationship between smoking and Dupuytren's contracture of the hand is explored in this article. One hundred thirty-two consecutive patients who had a partial fasciectomy for treatment of Dupuytren's contracture from 1980 to 1985, were analyzed retrospectively. There were 111 males and 21 females. Ninety (68.2%) of 132 patients smoked cigarettes compared with 110 (37.2%) of 296 randomized hospitalized control patients (p less than 0.00001). Eighty (72.1%) of 111 men smoked cigarettes compared with 65 (44.2%) of 147 male control patients (p = 0.000015). Cigarette smoking is linked statistically to Dupuytren's disease and may be involved in its pathogenesis by producing microvascular occlusion and subsequent fibrosis and contracture or by some other mechanism.

Entities:  

Mesh:

Year:  1988        PMID: 3225413     DOI: 10.1016/0363-5023(88)90262-6

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  10 in total

1.  Can rock climbing lead to Dupuytren's disease?

Authors:  A J Logan; G Mason; J Dias; N Makwana
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

2.  An insight into Dupuytren's contracture.

Authors:  G A Murrell
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

3.  The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren's Contracture.

Authors:  Gediminas Samulenas; Ruta Insodaite; Edita Kunceviciene; Roberta Poceviciute; Lorena Masionyte; Urte Zitkeviciute; Loreta Pilipaityte; Alina Smalinskiene
Journal:  Genes (Basel)       Date:  2022-04-23       Impact factor: 4.141

4.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease.

Authors:  Alexis Thomas; Ardeshir Bayat
Journal:  Ther Clin Risk Manag       Date:  2010-11-04       Impact factor: 2.423

5.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

6.  N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling.

Authors:  Jürgen Kopp; Harun Seyhan; Bastian Müller; Johanna Lanczak; Elke Pausch; Axel M Gressner; Steven Dooley; R E Horch
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

7.  Association between Stenosing Tenosynovitis and Dupuytren's Contracture in the Hand.

Authors:  Kai Yang; Michael Gehring; Savo Bou Zein Eddine; Patrick Hettinger
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-11

8.  Dupuytren's Contracture in Alabama HFE Hemochromatosis Probands.

Authors:  James C Barton; J Clayborn Barton
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-08-21

9.  Dupuytren's disease in Bosnia and Herzegovina. An epidemiological study.

Authors:  Dragan Zerajic; Vilhjalmur Finsen
Journal:  BMC Musculoskelet Disord       Date:  2004-03-29       Impact factor: 2.362

10.  Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren's Contracture.

Authors:  Gediminas Samulėnas; Alina Smalinskienė; Rytis Rimdeika; Kęstutis Braziulis; Mantas Fomkinas; Rokas Paškevičius
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.